480
Participants
Start Date
April 30, 2004
Study Completion Date
July 31, 2005
rPA102
Infectious Disease Unit, University of Rochester Medical Center, Rochester
Primary Physicians Research, Inc., Pittsburgh
Johns Hopkins University, Bloomberg School of Public Health, Baltimore
Emory Children's Clinic, Pediatric Infectious Disease, Atlanta
Vanderbilt University Medical Center, Nashville
Pediatric Clinical Trials Int'l, Inc. (PCTI), Columbus
Mayo Clinic College of Medicine, Rochester
St. Louis University, SoLUtions, St Louis
UCLA Ctr for Vaccine Research, LA Biomedical Research Institute, Torrance
University of Kentucky, Markey Cancer Center, Lexington
Cincinnati Children's Hospital Medical Center, Cincinnati
University of Vermont College of Medicine, Vermont Vaccine Evaluation Center, Burlington
Lead Sponsor
National Institutes of Health (NIH)
NIH
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Centers for Disease Control and Prevention
FED
VaxGen
INDUSTRY